LIMES Schlosskliniken (LIK) H2 2025 earnings summary

Executive summary

• Revenue rose 40% year-over-year to €53.1m, driven by strong demand across all clinics.

• Patient days increased 9% to 52,374, reflecting higher occupancy and utilization.

• Two new clinics launched, with Abtsee already profitable since January 2026 and Bergisches Land expected to break even in Q2 2026.

Financial highlights

• EBITDA grew 78% year-over-year to €12.8m, with margin improving to 24% from 19%.

• EBIT surged 112% to €9.2m; earnings before taxes up 116% to €8.9m.

• Cash flow per share increased to €43 from €24 in the prior year.

Outlook and guidance

• Solid development expected for existing clinics in 2026, with further sales and earnings growth anticipated from new clinics.

• Abtsee adolescent clinic expected to contribute positively for the full year; Bergisches Land clinic to reach break-even in early Q2 2026.